JPI Healthcare (CEO Jin-guk Kim), a digital X-ray imaging solution specialist, submitted a securities report to the Financial Services Commission on the 27th and began the KOSDAQ listing public offering schedule in earnest.
The total number of JPI Healthcare shares to be offered is 1.58 million, and the range of the desired offering price per share is 16,500 won to 20,000 won. The company will conduct a demand forecast for institutional investors from July 24 to 30 to determine the offering price, and will accept subscriptions on August 4 and 5. It is scheduled to be listed in August, and the lead underwriter is Kiwoom Securities.
Founded in 1980, JPI Healthcare is the world's No. 1 company in terms of market share for grids, a key component of X-ray imaging diagnosis. Grids are essential products that reduce scattered rays during X-ray diagnosis and improve image clarity. As the world's only company that produces grids made of both aluminum and carbon, it has approximately a 40% share of the global medical X-ray grid market. It carries out joint projects with key partners, including the world's top 10 medical device companies, and is establishing a strategic collaboration system from the development planning stage to product launch.
In addition to the grid, the company is expanding its business areas to include digital X-ray imaging equipment, imaging software, AI-based image analysis solutions, and cloud-based remote reading systems. The mobile hybrid CT 'DeteCT' and the multi-functional digital tomosynthesis (equipment that rotates the X-ray tube to take images from various angles) 'StriXion' provide accurate three-dimensional images in a short period of time while minimizing radiation exposure. It is also entering the pet medical market through the AI platform for veterinary imaging diagnosis 'VetBot AI'.
JPI Healthcare generates more than 80% of its total sales from overseas and exports its products to over 80 countries, including Germany, the United States, China, Italy, and Japan. It is currently doing business with over 300 clients around the world, and its strategy is to continue growing by expanding its product portfolio and expanding its business areas to include the industrial and security sectors.
JPI Healthcare CEO Jin-Gook Kim said, “JPI Healthcare is a total imaging solutions company that covers all areas of digital imaging diagnosis based on the world’s No. 1 technology in the medical X-ray field.” He added, “The KOSDAQ listing will be a turning point for the company to leap forward as a leading global digital imaging solution company, and we will continue to grow steadily by launching high value-added products and entering new markets.”
You must be logged in to post a comment.